In vitro melanoma models and transgenic BRAF/Pten mouse models demonstrated that Panx1 deletion increases T lymphocyte infiltration within the tumor microenvironment, although it does not significantly affect primary tumor formation, suggesting a dual role in tumor and immune regulation (61, 62). Here, BRAF is linked to neoplasm.